HURA
TuHURA Biosciences, Inc./NV
$2.05
+4.07%
$128.6M
No data for this timeframe.
Vol
Market Cap$128.6M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (90%)
Inst. Holders6 funds
Inst. Value$2.0M
Inst. Activity4 buys / 0 sells
Reddit Sentiment71° Bullish
SEC Reports6
Recent Activity
May 29, 2026
SEC
TuHURA Biosciences drew $1.7M from its $50M revolving credit facility with Parkview Holdings One LLC, the first draw und
8-K — Impact 4/10
May 28, 2026
Insider
Bianco James A. sold 150,000 shares
Chief Executive Officer @ $0.00 ($0.00)
May 19, 2026
short_volume
Short Volume: HURA — 65.6% short (0.3M / 0.5M)
Short: 344,365 | Exempt: 200 | TRF Vol: 524,645 | Short Ratio: 65.6% | Off-exchange volume (dark poo
May 15, 2026
SEC
TuHURA Biosciences reported Q1 2026 financial results with no revenue and a net loss per share of -$0.17, missing the co
8-K — Impact 4/10
Apr 22, 2026
SEC
TuHURA Biosciences secured a $50 million revolving credit facility from Parkview Holdings, an affiliate of its largest s
8-K — Impact 7/10
Feb 12, 2026
Insider
Ng George K sold 156,240 shares
Director @ $0.00 ($0.00)
Feb 12, 2026
Insider
Tendler Craig sold 156,240 shares
Director @ $0.00 ($0.00)
Inst.
MORGAN STANLEY — DOUBLED
176,197 shares ($133.3K)
Price Targets
$8.04
+298.0% upside
Strong Buy
Current $2.02
Low $6.20
Median $8.00
High $10.00
5 analysts
$6.20
$10.00
Analyst Ratings
2Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 27, 2026 | Citizens | INITIATE | Market Outperform |
| Feb 3, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.12 ▼ -4.3% | $-0.12 — $-0.12 | 43% YoY | 1 |
| Next Q | $-0.13 ▼ -4.0% | $-0.13 — $-0.13 | 7% YoY | 1 |
| Current FY | $-0.50 ▲ +2.6% | $-0.50 — $-0.50 | 24% YoY | 1 |
| Next FY | $-0.56 ▼ -6.3% | $-0.62 — $-0.52 | -1% YoY | 3 |
Latest Reports
NEUTRAL
8-K
4/10
TuHURA Biosciences drew $1.7M from its $50M revolving credit facility with Parkview Holdings One LLC, the first draw und
May 29, 2026
NEUTRAL
8-K
4/10
TuHURA Biosciences reported Q1 2026 financial results with no revenue and a net loss per share of -$0.17, missing the co
May 15, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $1.8M | DOUBLED |
| MORGAN STANLEY | $133.3K | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $62.0K | DOUBLED |
| BANK OF AMERICA CORP | $47.6K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $28.9K | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | Bianco James | G | $0.00 |
| Feb 12, 2026 | Ng George | A | $0.00 |
| Feb 12, 2026 | Tendler Craig | A | $0.00 |
| Feb 12, 2026 | MANUSO JAMES | A | $0.00 |
| Feb 12, 2026 | List Alan | A | $0.00 |
Reddit Sentiment
71°
Bullish
Bearish
Neutral
Bullish
6 institutional holders with $2.0M total value (2,686,576 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,319,762 | $1.8M | 86.4% | DOUBLED +398.4% |
| 2 | MORGAN STANLEY | 176,197 | $133.3K | 6.6% | DOUBLED +709.9% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 81,920 | $62.0K | 3.0% | DOUBLED +426.9% |
| 4 | BANK OF AMERICA CORP /DE/ | 63,007 | $47.6K | 2.3% | DOUBLED +748.5% |
| 5 | WELLS FARGO & COMPANY/MN | 38,208 | $28.9K | 1.4% | DOUBLED +109.0% |
| 6 | FMR LLC | 7,482 | $5.7K | 0.3% | DOUBLED +233.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | DOUBLED | 21,755 | 176,197 | +709.9% | $133.3K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 7,426 | 63,007 | +748.5% | $47.6K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 18,277 | 38,208 | +109.0% | $28.9K | 2025-Q4 |
| FMR LLC | DOUBLED | 2,241 | 7,482 | +233.9% | $5.7K | 2025-Q4 |
| UBS Group AG | TRIM | 256,004 | 141,475 | -44.7% | $350.9K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 34,121 | 21,755 | -36.2% | $54.0K | 2025-Q3 |
| FMR LLC | DOUBLED | 715 | 2,241 | +213.4% | $5.6K | 2025-Q3 |
| UBS Group AG | DOUBLED | 112,135 | 256,004 | +128.3% | $570.9K | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 15,000 | 79,032 | +426.9% | $176.2K | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 11,823 | 34,121 | +188.6% | $76.1K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 1,800 | 15,075 | +737.5% | $33.6K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 18,740 | 8,873 | -52.7% | $19.8K | 2025-Q2 |
| VANGUARD GROUP INC | DOUBLED | 376,319 | 1,875,533 | +398.4% | $6.1M | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 4,838 | 11,823 | +144.4% | $38.2K | 2025-Q1 |
| UBS Group AG | NEW | — | 93,333 | — | $381.7K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 15,000 | — | $61.4K | 2024-Q4 |
| MORGAN STANLEY | NEW | — | 4,838 | — | $19.8K | 2024-Q4 |
6 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | Bianco James A. | Chief Executive Officer | G | 150,000 | $0.00 | $0.00 |
| Feb 12, 2026 | Ng George K | Director | A | 156,240 | $0.00 | $0.00 |
| Feb 12, 2026 | Tendler Craig | Director | A | 156,240 | $0.00 | $0.00 |
| Feb 12, 2026 | MANUSO JAMES S J | Director | A | 156,240 | $0.00 | $0.00 |
| Feb 12, 2026 | List Alan | Director | A | 156,240 | $0.00 | $0.00 |
| Feb 12, 2026 | Hoffman Robert E. | Director | A | 156,240 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 1 mixed, 3 neutral. Avg impact: 5.7/10.
NEUTRAL
8-K
4/10
TuHURA Biosciences drew $1.7M from its $50M revolving credit facility with Parkview Holdings One LLC
May 29, 2026
NEUTRAL
8-K
4/10
TuHURA Biosciences reported Q1 2026 financial results with no revenue and a net loss per share of -$
May 15, 2026
MIXED
8-K
7/10
TuHURA Biosciences secured a $50 million revolving credit facility from Parkview Holdings, an affili
Apr 22, 2026
BEARISH
8-K
7/10
TuHURA Biosciences reported full-year 2025 financial results with no revenue and a net loss signific
Apr 21, 2026
NEUTRAL
8-K
5/10
TuHURA Biosciences completed its acquisition of Kineta and released updated pro forma financials sho
Apr 8, 2026
BEARISH
424B5
7/10
TuHURA Biosciences is conducting an at-the-market (ATM) offering of up to $50 million in common stoc
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (90% buy). Based on 10 analysts: 2 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$8.04 mean target
+298.0% upside
Strong Buy (1.50)
$6.20 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $2.02 |
| Target Low | $6.20 |
| Target Mean | $8.04 |
| Target Median | $8.00 |
| Target High | $10.00 |
| # Analysts | 5 |
| Recommendation | Strong Buy (1.50) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.12 | $-0.12 | $-0.12 | 42.9% | -4.3% | 1↑ 0↓ | $0.0B | 0.0% | 1 |
| Next Q 2026-09-30 |
$-0.13 | $-0.13 | $-0.13 | 7.1% | -4.0% | 1↑ 0↓ | $0.0B | 0.0% | 1 |
| Current FY 2026-12-31 |
$-0.50 | $-0.50 | $-0.50 | 23.8% | +2.6% | 1↑ 0↓ | $0.0B | 0.0% | 1 |
| Next FY 2027-12-31 |
$-0.56 | $-0.62 | $-0.52 | -0.6% | -6.3% | 0↑ 1↓ | $0.0B | 0.0% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.120 | |
| 7d ago | $-0.115 | -0.005 |
| 30d ago | $-0.115 | -0.005 |
| 60d ago | $-0.115 | -0.005 |
| 90d ago | $-0.115 | -0.005 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 27, 2026 | Citizens | INITIATE | — | Market Outperform |
| Feb 3, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| May 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Apr 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Jan 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
71°
Bullish
Bearish
Neutral
Bullish
3 mentions
3 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 11, 2026 | 2 | 67° Warm | 2 | 0 | 2 |
| Feb 10, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
$KIDZ watch this one
▲ 2
💬 4
⚡ 0.0
$KIDZ next possible $QCNX
▲ 7
💬 6
⚡ 0.0
$HURA Is a Buy
▲ 1
💬 3
⚡ 0.0
May 19, 2026
short_volume
Short Volume: HURA — 65.6% short (0.3M / 0.5M)
Short: 344,365 | Exempt: 200 | TRF Vol: 524,645 | Short Ratio: 65.6% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: HURA — 58.8% short (0.3M / 0.6M)
Short: 344,166 | Exempt: 0 | TRF Vol: 585,524 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Apr 23, 2026
short_volume
Short Volume: HURA — 64.3% short (0.7M / 1.0M)
Short: 668,894 | Exempt: 13,140 | TRF Vol: 1,039,874 | Short Ratio: 64.3% | Off-exchange volume (dark pool + OTC)
Apr 17, 2026
short_volume
Short Volume: HURA — 60.5% short (0.5M / 0.8M)
Short: 469,495 | Exempt: 27,580 | TRF Vol: 776,146 | Short Ratio: 60.5% | Off-exchange volume (dark pool + OTC)
Apr 16, 2026
short_volume
Short Volume: HURA — 57.7% short (0.4M / 0.6M)
Short: 368,289 | Exempt: 2,467 | TRF Vol: 637,955 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
short_volume
Short Volume: HURA — 60.2% short (0.6M / 0.9M)
Short: 561,441 | Exempt: 4,236 | TRF Vol: 932,521 | Short Ratio: 60.2% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: HURA — 59.4% short (0.8M / 1.4M)
Short: 844,154 | Exempt: 28,084 | TRF Vol: 1,420,341 | Short Ratio: 59.4% | Off-exchange volume (dark pool + OTC)
Apr 13, 2026
short_volume
Short Volume: HURA — 61.7% short (1.4M / 2.3M)
Short: 1,430,489 | Exempt: 9,044 | TRF Vol: 2,319,833 | Short Ratio: 61.7% | Off-exchange volume (dark pool + OTC)
Apr 10, 2026
short_volume
Short Volume: HURA — 58.1% short (0.6M / 1.0M)
Short: 577,051 | Exempt: 0 | TRF Vol: 993,677 | Short Ratio: 58.1% | Off-exchange volume (dark pool + OTC)
Apr 9, 2026
short_volume
Short Volume: HURA — 69.7% short (0.5M / 0.7M)
Short: 466,581 | Exempt: 4,635 | TRF Vol: 669,049 | Short Ratio: 69.7% | Off-exchange volume (dark pool + OTC)
Apr 8, 2026
short_volume
Short Volume: HURA — 70.1% short (0.5M / 0.7M)
Short: 490,292 | Exempt: 45,530 | TRF Vol: 699,861 | Short Ratio: 70.1% | Off-exchange volume (dark pool + OTC)
Apr 7, 2026
short_volume
Short Volume: HURA — 81.6% short (0.5M / 0.7M)
Short: 537,077 | Exempt: 19,432 | TRF Vol: 658,178 | Short Ratio: 81.6% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
short_volume
Short Volume: HURA — 71.7% short (0.5M / 0.7M)
Short: 515,836 | Exempt: 24,714 | TRF Vol: 719,563 | Short Ratio: 71.7% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_volume
Short Volume: HURA — 71.8% short (0.5M / 0.7M)
Short: 503,795 | Exempt: 127,340 | TRF Vol: 701,431 | Short Ratio: 71.8% | Off-exchange volume (dark pool + OTC)
Feb 11, 2026
short_interest
FTD: HURA — 539,075 shares ($0.7M) failed to deliver
Settlement: 20260211, Price: $1.30, FTD Value: $700,797.5, TUHURA BIOSCIENCES INC COM